Search images on Google      Product Monograph

Active Ingredients:

• risankizumab, 60 MG/ML

DIN: 02532107

Dosage Form(s): SOLUTION

Route(s) of Administration: INTRAVENOUS

Description: SINGLE USE VIAL

Schedule: Prescription

Company: ABBVIE CORPORATION

ATC:

• L04 - IMMUNOSUPPRESSANTS (ATC, WHO, Wiki)
• L04A - IMMUNOSUPPRESSANTS (ATC, WHO)
• L04AC - Interleukin inhibitors (ATC, WHO)
• L04AC18 - RIZANKIZUMAB (WHO)

 

External Links for Skyrizi:

Search on Google

• Skyrizi side effects
• Skyrizi dosage
• risankizumab side effects
• risankizumab dosage